datetime,headline,summary,related,lang,source
2020-10-30 10:31:00-05:00,USAA Appoints Dona Young to Board of Directors,"SAN ANTONIO , Oct. 30, 2020 /PRNewswire/ -- USAA has added Dona Young to its Board of Directors. Ms. Young will serve as a member of the Nominating and Governance, Audit, and Compensation and Workforce committees. Ms. Young has extensive experience in insurance and financial services including a focus on leadership and talent development. She is the former chair, chief executive officer and president of Phoenix Companies. Currently, she serves as an independent Director on the Supervisory Board of Aegon NV and chair of its risk committee as well as on the Advisory Board of … Full story available on Benzinga.com",AEG,en,Benzinga
2020-10-25 02:18:47-05:00,Aegon (NYSE:AEG) Rating Lowered to Hold at Zacks Investment Research,"Zacks Investment Research cut shares of Aegon (NYSE:AEG) from a buy rating to a hold rating in a research note published on Wednesday, Zacks.com reports. According to Zacks, “Aegon N.V. is an international insurance group which writes life and health insurance and offers related pension, savings and investment products in Europe, North America and the […]",AEG,en,Transcript Daily
2020-10-24 03:19:09-05:00,Zacks Investment Research Lowers AEGON (NYSE:AEG) to Hold,"Zacks Investment Research downgraded shares of AEGON (NYSE:AEG) from a buy rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Aegon N.V. is an international insurance group which writes life and health insurance and offers related pension, savings and investment products in Europe, North America and the Caribbean. […]",AEG,en,Stock Observer
2020-10-23 00:32:44-05:00,AEGON (NYSE:AEG) Cut to Hold at Zacks Investment Research,"AEGON (NYSE:AEG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Aegon N.V. is an international insurance group which writes life and health insurance and offers related pension, savings and investment products in Europe, […]",AEG,en,Zolmax News
2020-10-22 20:32:44-05:00,AEGON (NYSE:AEG) Stock Rating Lowered by Zacks Investment Research,"AEGON (NYSE:AEG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Aegon N.V. is an international insurance group which writes life and health insurance and offers related pension, savings and investment products in Europe, North America and the […]",AEG,en,Dispatch Tribunal
2020-10-21 12:08:42-05:00,AEGON (NYSE:AEG) Downgraded by Zacks Investment Research to “Hold”,"AEGON (NYSE:AEG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Aegon N.V. is an international insurance group which writes life and health insurance and offers related pension, savings and investment products in Europe, North America and the […]",AEG,en,The Olympia Report
2020-09-25 07:47:53-05:00,Oberholzer cleared of wrongdoing regarding Aveng payment dispute,The High Court ruling has officially vindicated Eskom COO Jan Oberholzer's stance on the payment dispute with contractor Aveng.,AEG,en,TheSouthAfrican
2020-09-04 01:00:00-05:00,Active Energy Group - Awarded London Stock Exchange's Green Economy Mark - Vox Markets,"RNS Number: 0031 Y Active Energy Group PLC 04 September 2020 Active Energy Group Plc/ EPIC: AEG/ Sector: Alternative Energy. Awarded London Stock Exchange's Green Economy Mark. Active Energy, the international biomass based renewable energy business, is delighted to announce that it has been awarded the Green Economy Mark by the London Stock Exchange..",AEG,en,VOX Markets
2020-08-20 10:00:32-05:00,Active Energy raises £1.5m to advance Lumberton site,"Biomass-based renewable energy company Active Energy has raised £1.51m, it announced on Thursday, to advance its Lumberton site in the US.",AEG,en,Share Cast
2020-08-13 19:00:00-05:00,Aegon NV Quartalszahlen: Gewinnerwartung und Umsatzprognose im Q2 übertroffen,Aegon NV Quartalszahlen: Gewinnerwartung und Umsatzprognose im Q2 übertroffen,AEG,de,Investing.com Germany
2020-08-13 11:04:40-05:00,AEGON-Aktie bricht zweistellig ein: AEGON nimmt Ausblick nach Gewinneinbruch zurück,"Wie die AEGON NV ankündigte, will sie für den Berichtszeitraum nur noch eine Dividende von 6 Cent je Aktie zahlen nach 15 Cent vor einem Jahr. Der Nettogewinn brach von Januar bis Juni um 67 Prozent auf 202 Millionen Euro ein. Der bereinigte Vorsteuergewinn sackte…",AEG,de,Finanzen CH
2020-08-13 02:40:40-05:00,AEGON-Aktie bricht ein: AEGON nimmt Ausblick nach Gewinneinbruch zurück,"Wie die AEGON NV ankündigte, will sie für den Berichtszeitraum nur noch eine Dividende von 6 Cent je Aktie zahlen nach 15 Cent vor einem Jahr. Der Nettogewinn brach von Januar bis Juni um 67 Prozent auf 202 Millionen Euro ein. Der bereinigte Vorsteuergewinn sackte…",AEG,de,Finanzen CH
2020-07-21 04:45:00-05:00,Aegon N.V. : The comeback of an upward trend can be anticipated | MarketScreener,"Aegon N.V. reflects attractive technical aspects that could allow investors to expect a trend reversal over the medium term. | July 21, 2020",AEG,en,MarketScreener
2020-06-22 07:41:58-05:00,Active Energy raises £0.8m as it expands Lumberton operations,"Biomass-based renewable energy company Active Energy has completed a fundraise of £0.8m before expenses, it announced on Monday, through the subscription of convertible loan notes by new United States and existing European investors.",AEG,en,Share Cast
2020-06-01 06:11:06-05:00,Active Energy : Download Annual Report 2019 | MarketScreener,"ACTIVE ENERGY GROUP PLC ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2019 Company Registration Number: 03148295 … | June 1, 2020",AEG,en,MarketScreener
2020-05-26 23:54:45-05:00,Fintech startup GoBear raises US$17m in funding,"FINANCIAL products comparison site GoBear on Wednesday said it has raised US$17 million from Dutch venture capital firm Walvis Participaties, as well as Aegon NV, a provider of life insurance, pensions and asset management. Read more at The Business Times.",AEG,en,The Business Times
2020-05-06 10:50:15-05:00,Is Aegon NV (AEG) Stock Undervalued Right Now?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","AGN,AEG",en,Zacks Investment Research
2020-02-27 10:23:40-05:00,Fin24.com | Aveng takes Leonardo dispute to adjudicator,"Construction firm Aveng has taken its dispute with the developers of The Leonardo - the tallest building in Africa - to the adjudicator, but says whatever the outcome, it will not return to the project.",AEG,en,Fin24
2020-02-17 02:08:50-05:00,Active Energy : Publication of Open Letter | MarketScreener,"RNS Reach Story Go to market news section … | February 17, 2020",AEG,en,MarketScreener
2020-02-14 04:58:21-05:00,Active Energy : Bondholders Agreement to Revise Existing Terms | MarketScreener,"Active Energy Group Plc / EPIC: AEG / Sector: Alternative Energy 14 February 2020 Active Energy Group Plc … | February 14, 2020",AEG,en,MarketScreener
2020-02-07 10:15:41-05:00,Active Energy upbeat on developments at Lumberton,Biomass-based renewable energy company Active Energy updated the market on its current activities at the Lumberton site in North Carolina on Friday.,AEG,en,Share Cast
2020-01-20 02:39:07-05:00,Active Energy : Board Appointments | MarketScreener,"Active Energy Group Plc / EPIC: AEG / Sector: Alternative Energy 20 January 2020 Active Energy Group Plc … | January 20, 2020",AEG,en,MarketScreener
2020-01-09 11:08:23-05:00,Fin24.com | Troubled construction firm Aveng loses contract for the tallest building in Africa,"The Leonardo owners have also called on the construction guarantee, a surety bond that Aveng put up when it signed the contract. This has put Aveng in the red by R87.4m.",AEG,en,Fin24
2019-12-13 08:10:02-05:00,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer","The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) (received approval for its bone-building osteoporosis drug in the U.S.) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Avenue Therapeutics Inc (NASDAQ: ATXI ) (submitted the NDA for intravenous tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting) Bausch Health Companies Inc (NYSE: BHC ) (reacted to upgrade to Overweight rating by JPMorgan) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Boston Scientific Corporation (NYSE: BSX ) Bristol-Myers Squibb Co (NYSE: BMY ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) Globus Medical Inc (NYSE: GMED ) (reacted to upgrade to Overweight by Wells Fargo Securities) Gossamer Bio Inc (NASDAQ: GOSS ) Hologic, Inc.","AGN,AEG,AEZS,AEMD",en,Benzinga Feeds
2019-12-11 05:38:37-05:00,Active Energy awaits decision on permits for Lumberton site,"Biomass-based renewable energy company Active Energy updated the market on its activities at its commercial hub in Lumberton, United States on Wednesday, after it announced on 25 September that it had applied for the relevant air and environmental permits from the North Carolina Department of Environment and Natural Resources (NCDENR).",AEG,en,Share Cast
2019-12-11 02:00:00-05:00,Active Energy Group - Update on JV Lumber Activities at Lumberton - Vox Markets,"Update on JV Lumber Activities at Lumberton. Active Energy, the London quoted international biomass based renewable energy business, announces an update regarding lumber related activities through its joint venture company Renewable Energy Systems LLC at its large-scale, integrated forest-to-energy, commercial hub in Lumberton, USA.",AEG,en,VOX Markets
2019-12-06 07:39:38-05:00,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(presented positive Phase 3 data for pimavanserin in dementia-related psychosis) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH )( reported positive readout for a pivotal trial in volcosporin for lupus nephritis) Bristol-Myers Squibb Co (NYSE: BMY ) Cassava Sciences Inc (NASDAQ: SAVA ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Incyte Corporation (NASDAQ: INCY ) Merck & Co., Inc. (NYSE: MRK ) Morphosys Ag (NASDAQ: MOR ) NuVasive, Inc. (NASDAQ: NUVA ) Oyster Point Pharma Inc (NASDAQ: OYST ) PTC Therapeutics, Inc.","AGN,AEG",en,Benzinga
2019-12-05 07:14:16-05:00,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) Allakos Inc (NASDAQ: ALLK )(announced exploration of strategic options, including a potential sale) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Bausch Health Companies Inc (NYSE: BHC ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Incyte Corporation (NASDAQ: INCY ) Inspire Medical Systems Inc (NYSE: INSP ) IVERIC bio Inc (NASDAQ: ISEE ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Kodiak Sciences Inc (NASDAQ: KOD ) Krystal Biotech Inc (NASDAQ: KRYS ) Merck & Co.","AGN,AEG",en,Benzinga
2019-11-28 10:04:19-05:00,Active Energy Group receives inaugural licence agreement for CoalSwitch™ - Vox Markets,"As part of the agreement, RMDE has paid a license fee of US$ 1.8 million to Active Energy who will subsequently receive royalty payments of US$5.00 per tonne on licensed products produced by RMDE, its clients or partners.",AEG,en,VOX Markets
2019-11-28 06:04:36-05:00,Active Energy signs licence deal with Canadian forestry management firm,Biomass-focussed renewable energy business Active Energy Group has agreed terms for the issuance of its first ‘CoalSwitch’ licence agreement to RMD Environmentals - a Canada-based forestry management and environmental engineering and consultancy business.,AEG,en,Share Cast
2019-11-22 01:41:00-05:00,"Enconnex adquire divisão Active Energy Solutions da Methode Electronics, Inc.","RENO, Nevada--(BUSINESS WIRE)--A Enconnex anunciou hoje que adquiriu os ativos da Active Energy Solutions (AES), uma divisão da Methode Electronics Inc., fortalecendo o relacionamento de longo prazo entre as duas empresas. No acordo de distribuição exclusiva com a AES, a Enconnex irá oferecer a fonte de alimentação ininterrupta (uninterruptible Power Supply, UPS) AC6000 a seus clientes. A Enconnex inaugurou uma nova unidade de produção em sua sede em Reno, Nevada, e já incorporou o produto às s",AEG,pt,Business Wire
2019-11-21 22:59:00-05:00,"Enconnex übernimmt die Abteilung Active Energy Solutions von Methode Electronics, Inc.","RENO, Nevada (USA)--(BUSINESS WIRE)--Enconnex hat heute bekanntgegeben, dass das Unternehmen Aktiva von Active Energy Solutions (AES), einer Abteilung von Methode Electronics, Inc., übernommen und damit die langjährige Beziehung zwischen den beiden Firmen bekräftigt hat. Gemäß einer exklusiven Vertriebsvereinbarung mit AES hat Enconnex seinen Kunden die unterbrechungsfreie Stromversorgung (USV) AC6000 angeboten. Enconnex hat eine neue Fertigungsanlage an seinem Firmensitz in Reno, Nevada gegrün",AEG,de,Business Wire
2019-11-21 22:59:00-05:00,"Enconnex fait l’acquisition de la division Active Energy Solutions de Methode Electronics, Inc.","RENO, Nevada--(BUSINESS WIRE)--Enconnex a annoncé aujourd’hui qu’elle avait fait l’acquisition d’Active Energy Solutions (AES), une division de Methode Electronics, Inc., consolidant ainsi la relation à long terme entre les deux sociétés. Dans le cadre d’un accord de distribution avec AES, Enconnex propose le système d’alimentation sans interruption (ASI) AC6000 à ses clients. Enconnex a créé une nouvelle installation de production dans son siège de Reno, au Nevada, et incorporé le produit dans",AEG,fr,Business Wire
2019-11-21 18:05:00-05:00,"Enconnex Adquiere la División Active Energy Solutions de Methode Electronics, Inc.","RENO, Nevada--(BUSINESS WIRE)--Enconnex anunció hoy que ha adquirido activos de Active Energy Solutions (AES), una división de Methode Electronics, Inc., al consolidar la relación a largo plazo entre las dos empresas. Según un acuerdo de distribución exclusivo con AES, Enconnex ha estado ofreciendo el suministro de alimentación ininterrumpida (uninterruptible power supply, UPS) AC6000 a sus clientes. Enconnex ha establecido una nueva planta de fabricación en su sede de Reno, Nevada, y ha incorp",AEG,es,Business Wire
2019-11-20 07:25:05-05:00,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Allergan plc (NYSE: AGN )(announced publication of Phase 3 study results of migraine drug candidate) Agenus Inc (NASDAQ: AGEN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS )(announced a collaboration agreement with Idorsia Pharma for developing a drug-device combo for heart attack) Ardelyx Inc (NASDAQ: ARDX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) CNS Pharmaceuticals Inc (NASDAQ: CNSP )(IPOed Nov. 8) Crispr Therapeutics AG (NASDAQ: CRSP )( announced positive Phase 1/2 results for gene-editing investigational therapy) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Galera Therapeutics Inc (NASDAQ: GRTX )(IPOed Nov.","AGEN,AGN,AEG,AEMD",en,Benzinga
2019-11-14 10:05:26-05:00,"Allergan, Exicure Strike Collaboration Agreement For Hair Loss Disorder Drugs","Shares of the thinly traded micro-cap Exicure Inc (NASDAQ: XCUR ) were advancing strongly Thursday in the wake of a collaboration agreement announced by the company with Allergan plc (NYSE: AGN ). Exicure Receives $25M Upfront Exicure — a biotech company developing therapies for immuno-oncology, inflammatory diseases and genetic disorders — said the collaboration agreement pertains to discovery and development of novel treatments for hair loss disorders based on its proprietary SNA technology. The agreement provides for Allergan receiving exclusive access and options to license SNA-based therapeutics arising from two collaboration programs by making an upfront payment of $25 million to Exicure. The latter will conduct discovery and development in the two programs for hair loss disorders. If Allergan exercises an … Full story available on Benzinga.com","AGN,AEG",en,Benzinga Feeds
2019-11-13 07:10:18-05:00,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) Crispr Therapeutics AG (NASDAQ: CRSP ) Diplomat Pharmacy Inc (NYSE: DPLO )( warned of going concern risk) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ: XOMA ) Zai Lab Ltd (NASDAQ: ZLAB ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov.","AGN,AEG,AFMD",en,Benzinga
2019-11-05 10:48:59-05:00,Allergan's Q3 Sales Get A Facelift From Botox; AbbVie Deal On Track,"Botox maker Allergan plc (NYSE: AGN ), which has agreed to be bought by AbbVie Inc (NYSE: ABBV ) for $63 billion, reported Tuesday ahead of the open with higher third-quarter revenue and an adjusted loss that was wider than expected. The company said its pending acquisition by AbbVie is on schedule. Botox Boost For Top Line Allergan said its third-quarter total net revenue climbed 3.6% year-over-year to $4.05 billion, ahead of the $3.88-billion consensus estimate. Non-GAAP net revenues improved from $3.91 billion to $4.03 billion. The company attributed the year-over-year growth to strong sales of the antipsychotic drug Vraylar, Botox Cosmetic, Juvederm, Botox Therapeutic, Ozurdex and Lo Loestrin. Vraylar sales grew 70% and U.S. Botox … Full story available on Benzinga.com","AGN,AEG",en,Benzinga
2019-08-06 06:32:06-05:00,"Allergan Reports Q2 Earnings Beat, Reaffirms Guidance","Allergan (NYSE: AGN ) reported second-quarter earnings of $4.38 per share, which beat the analyst consensus estimate of $4.34 by 0.92%. This is a 0.9% decrease over earnings of $4.42 per share from the same period last year. The company reported quarterly sales of $4.09 billion, which beat the analyst consensus estimate of $3.93 billion by 4.07%. This is … Full story available on Benzinga.com","AGN,AEG",en,Benzinga
2019-06-26 06:19:56-05:00,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 25) ArQule, Inc. (NASDAQ: ARQL ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 25) AbbVie Inc (NYSE: ABBV )(announced a deal to buy Allergan plc (NYSE: AGN ) for $63 billion) Acer Therapeutics Inc (NASDAQ: ACER )(The FDA issued complete response letter to its rare disease drug Edsivo) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aldeyra Therapeutics Inc (NASDAQ: ALDX )( reported negative results for the late-stage study that evaluated its reproxalap in anterior uveitis) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Axcella Health Inc (NASDAQ: AXLA ) Biopharmx Corp NYSE: (BPMX) (reported positive results for a Phase 2b clinical trial of BPX-04 in treating moderate-to-severe papulopustular rosacea) CELYAD SA/ADR (NASDAQ: CYAD ) Conatus Pharmaceuticals Inc (NASDAQ: CNAT )( announced decision to explore strategic alternatives following failed NASH drug trial) Enochian Biosciences Inc (NASDAQ: ENOB ) Evolent Health Inc (NYSE: EVH ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Myriad Genetics, Inc.","AGN,AEG,AERI",en,Benzinga
2019-06-19 09:22:11-05:00,"Ironwood, Allergan Investors React Positively After Duo's Constipation Drug Found Effective","Shares of the small-cap, actively traded Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) were seeing positive momentum Wednesday on top of the 8.08% gain the stock recorded Tuesday. What Happened Ironwood and Allergan plc (NYSE: AGN ) announced positive topline results from a Phase 3b study evaluating Linzess 290 mcg for multiple abdominal symptoms in adult patients with irritable bowel syndrome with constipation, or IBS-C. The companies said the late-stage study met the primary multicomponent endpoint of the drug, when administered orally once-daily, demonstrating an improvement in overall abdominal symptoms of bloating, pain and discomfort in … Full story available on Benzinga.com","AGN,AEG",en,Benzinga
2019-06-07 08:30:00-05:00,Is Aegon NV (AEG) a Suitable Stock for Value Investors Now?,Let's see if Aegon NV (AEG) stock is a good choice for value-oriented investors right now from multiple angles.,"AGN,AEG",en,Zacks Investment Research
2019-05-30 06:33:27-05:00,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 29) Chiasma Inc (NASDAQ: CHMA ) Soliton Inc (NASDAQ: SOLY )( reacted to the news of the initiation of cellulite trial) Eidos Therapeutics Inc (NASDAQ: EIDX ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 29) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) Allergan plc (NYSE: AGN ) AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) Aptinyx Inc (NASDAQ: APTX ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) CAN-FITE BIOPHA/S ADR (NYSE: CANF )(reacted to its first-quarter results and an update on clinical trial progress) Cidara Therapeutics Inc (NASDAQ: CDTX ) Diplomat Pharmacy Inc (NYSE: DPLO ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Emergent Biosolutions Inc (NYSE: EBS ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Hookipa Pharma Inc (NASDAQ: HOOK ) IMMURON LTD/S ADR (NASDAQ: IMRN ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Opko Health Inc. (NASDAQ: OPK ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA )( downgraded by UBS to Neutral on its legal woes) Theravance Biopharma Inc (NASDAQ: TBPH ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Stock In Focus Unity …","AGN,AEG",en,Benzinga
2019-05-26 16:03:35-05:00,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,"After two successive weeks of losses, biotech stocks slowly clawed back. Multiple conference presentations, independent clinical trial readouts and a few FDA decisions marked the key events in the biotech space. Among the notable biotech movers of the week: BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), which suffered a severe setback despite a positive readout from a late-stage trial of its investigational drug for preventing hereditary angioedema. The massive four-day rally in Outlook Therapeutics Inc (NASDAQ: OTLK ) took a break. The following are catalysts that could set the tone for trading in biotech stocks in the upcoming week. Conferences The American Society of Clinical Pyschopharmacology 2019 Annual Meeting: May 28-31 in Scottsdale, Arizona. 27th Annual Congress on Cell Signaling, Cancer Science and Therapeutics: May 30-31 in Orlando, Florida. The American Society of Clinical Oncology, or ASCO, 2019 Annual Meeting: May 31–June 4 in Chicago, Illinois. PDUFA Dates The FDA is likely to issue its verdict on Novartis AG (NYSE: NVS )'s gene therapy candidate Zolgensma for spinal muscular atrophy Type 1.","AGN,AEG",en,Benzinga
2019-05-23 08:10:10-05:00,Should Value Investors Buy Aegon NV (AEG) Stock?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","AGN,AEG",en,Zacks Investment Research
2019-05-07 08:10:10-05:00,Is Aegon NV (AEG) Stock Undervalued Right Now?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","AGN,AEG",en,Zacks Investment Research
2019-05-07 07:45:00-05:00,Glaucoma Treatment and Therapeutics Market Projected to Have Strong Growth Rate Through 2028,"PALM BEACH, Florida , May 7, 2019 /PRNewswire/ -- The patient demand for a better way to treat to glaucoma has been growing for years. Two recent reports from Transparency Market Research show that this growing worldwide consumer demand projects ever increasing revenues for both the Treatment and Therapeutic markets and for hope for the consumers for a better solution. The reports said: ""A new exhaustive report collated by Transparency Market Research envisages an average growth for the global glaucoma treatment market in the period between 2017 and 2026. More than US$ 3,300 revenues are expected to be gained from treatment of glaucoma across the globe by 2026-end… (and) The global glaucoma therapeutics market was valued at US$ 5,932.6 Mn in 2017 is anticipated to reach US$ 7,659.8 Mn by 2026, expanding at a CAGR of 2.9% from 2018 to 2026. Increase in prevalence and incidence of diabetic disorders, rise in geriatric population, improved health care as well as health care infrastructure, introduction of combination therapies, and surge in the number of awareness programs are likely to drive the global glaucoma therapeutics market during the forecast period."" The reports continued saying that: "" North America to Remain Leading Revenue Contributor to Global Glaucoma Treatment Market… Incidences of glaucoma in North American countries are rising significantly, with the surge in older population in the region, thereby creating high demand for glaucoma drugs…","AGN,AEG",en,Benzinga
2019-02-18 16:06:30-05:00,Aegon NV (AEG) CEO Alex Wynaendts on Q4 2018 Results - Earnings Call Transcript,"Aegon NV (NYSE:AEG) Q4 2018 Earnings Conference Call February 13, 2019 03:00 AM ET Company Participants Jan Weidema - Head, IR Alex Wynaendts - CEO Matt Rider -","AGN,AEG",en,Seeking Alpha
